Literature DB >> 3298041

Renal function curve in patients with secondary forms of hypertension.

G Kimura, F Saito, S Kojima, H Yoshimi, H Abe, Y Kawano, K Yoshida, T Ashida, M Kawamura, M Kuramochi.   

Abstract

The causative mechanisms of hypertension were investigated by studying the renal function (pressure-natriuresis) curve in patients with primary aldosteronism (n = 6) and renovascular hypertension (n = 6). Before and after radical operation (removal of adenoma in primary aldosteronism and percutaneous transluminal angioplasty in renovascular hypertension), dietary NaCl intake was altered from 10 to 13 g/day in Week 1 to 1 to 3 g/day in Week 2. Mean arterial pressure (MAP) and urinary sodium excretion were measured on the last 3 days of each week. By restricting sodium intake before operation, MAP was reduced from 122 +/- 7 to 113 +/- 7 mm Hg (p less than 0.025) in primary aldosteronism but not in renovascular hypertension (130 +/- 6 to 128 +/- 5 mm Hg). The renal function curve was drawn by plotting urinary sodium excretion on the ordinate and MAP on the abscissa before and after operation. The slope of the curve was analyzed between the plotted points, and each curve was extrapolated to zero sodium excretion as an estimate of the degree of shift of the curve along the MAP axis. Before, as compared with after operation, the extrapolated x-intercept of the curve was shifted rightward in both primary aldosteronism (111 +/- 7 vs 87 +/- 4 mm Hg; p less than 0.025) and renovascular hypertension (128 +/- 5 vs 95 +/- 2 mm Hg; p less than 0.025) and the slope was depressed in primary aldosteronism (16 +/- 1 vs 40 +/- 17 [mEq/day]/mm Hg; p less than 0.025) but not in renovascular hypertension (130 +/- 75 vs 40 +/- 13 [mEq/day]/mm Hg).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3298041     DOI: 10.1161/01.hyp.10.1.11

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  10 in total

Review 1.  Pathophysiology and treatment of resistant hypertension: the role of aldosterone and amiloride-sensitive sodium channels.

Authors:  Eric K Judd; David A Calhoun; David G Warnock
Journal:  Semin Nephrol       Date:  2014       Impact factor: 5.299

Review 2.  Glomerular function reserve and sodium sensitivity.

Authors:  Genjiro Kimura
Journal:  Clin Exp Nephrol       Date:  2005-06       Impact factor: 2.801

3.  Intrarenal hemodynamics in primary aldosteronism before and after treatment.

Authors:  Leonardo A Sechi; Alessandro Di Fabio; Massimo Bazzocchi; Alessandro Uzzau; Cristiana Catena
Journal:  J Clin Endocrinol Metab       Date:  2009-01-13       Impact factor: 5.958

Review 4.  The impact of excessive salt intake on human health.

Authors:  Robert W Hunter; Neeraj Dhaun; Matthew A Bailey
Journal:  Nat Rev Nephrol       Date:  2022-01-20       Impact factor: 28.314

Review 5.  The kidneys and aldosterone/mineralocorticoid receptor system in salt-sensitive hypertension.

Authors:  Shigeru Shibata; Toshiro Fujita
Journal:  Curr Hypertens Rep       Date:  2011-04       Impact factor: 5.369

Review 6.  Treatment of Primary Aldosteronism and Organ Protection.

Authors:  Cristiana Catena; GianLuca Colussi; Leonardo A Sechi
Journal:  Int J Endocrinol       Date:  2015-05-17       Impact factor: 3.257

7.  Effective prevention of sorafenib-related vascular damage induced adverse events and maintenance of hepatic function by dried bonito broth and histidine.

Authors:  Norihiro Sakai; Kenya Kamimura; Yoko Shinagawa-Kobayashi; Takuro Nagoya; Yusuke Niwa; Masayoshi Ko; Toru Setsu; Akira Sakamaki; Takeshi Yokoo; Satoshi Abe; Hiroteru Kamimura; Soichi Sugitani; Masahiko Yanagi; Shuji Terai
Journal:  Cancer Manag Res       Date:  2019-05-13       Impact factor: 3.989

8.  Impaired pressure natriuresis and non-dipping blood pressure in rats with early type 1 diabetes mellitus.

Authors:  Geoffrey J Culshaw; Hannah M Costello; David Binnie; Kevin R Stewart; Alicja Czopek; Neeraj Dhaun; Patrick W F Hadoke; David J Webb; Matthew A Bailey
Journal:  J Physiol       Date:  2018-12-23       Impact factor: 5.182

Review 9.  How Do Antihypertensive Drugs Work? Insights from Studies of the Renal Regulation of Arterial Blood Pressure.

Authors:  Holly Digne-Malcolm; Matthew C Frise; Keith L Dorrington
Journal:  Front Physiol       Date:  2016-07-29       Impact factor: 4.566

10.  L/T-type calcium channel blocker reduces non-Gaussianity of heart rate variability in chronic kidney disease patients under preceding treatment with ARB.

Authors:  Michio Fukuda; Yoshiaki Ogiyama; Ryo Sato; Toshiyuki Miura; Hidekatsu Fukuta; Masashi Mizuno; Ken Kiyono; Yoshiharu Yamamoto; Junichiro Hayano; Nobuyuki Ohte
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2016-04-18       Impact factor: 1.636

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.